Yizhi Wang
-
- Pancreatic and Hepatic Oncology Research 8
- Cancer Immunotherapy and Biomarkers 4
-
- Ferroptosis and cancer prognosis 9
-
- Cancer-related molecular mechanisms research 5
- Marketing top 10%
-
- Energy, Environment, Economic Growth 5
- Market Dynamics and Volatility 4
-
- RNA modifications and cancer 5
-
- Acute Myeloid Leukemia Research 3
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yizhi Wang
52 papers receiving 641 citations
Peers
Comparison fields: 5 of 122
- Oncology 231
- Pulmonary and Respiratory Medicine 173
- Cancer Research 77
- Marketing 45
- Immunology 84
Countries citing papers authored by Yizhi Wang
This map shows the geographic impact of Yizhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhi Wang more than expected).
Fields of papers citing papers by Yizhi Wang
This network shows the impact of papers produced by Yizhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhi Wang. The network helps show where Yizhi Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yizhi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 16 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 63 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 1 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 15 | |
| 16 | 2021 | 19 | |
| 17 | 2021 | 16 | |
| 18 | 2021 | 9 | |
| 19 | 2020 | 71 | |
| 20 | 2020 | 41 |
About Yizhi Wang
Yizhi Wang is a scholar working on Oncology, General Decision Sciences and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 649 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Energy, Environment, Economic Growth (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), Market Dynamics and Volatility (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Oncology (231 citations), Pulmonary and Respiratory Medicine (173 citations) and Cancer Research (77 citations). Yizhi Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Dongyang Zhang, Jun Lü, Junchao Guo, Li Zhou, Samuel A. Vigne, Qunxi Kong, Hao Long, Lei You, Yaobin Lin and Chengxi Liu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.